Literature DB >> 33884523

Our greatest untapped resource: our patients.

Matt Bolz-Johnson1, Tom Kenny2, Yann Le Cam3, Ines Hernando3.   

Abstract

Healthcare is continually evolving to meet the changing needs of twenty-first century populations whilst striving to keeping pace with medical and technological advancements. Patients and clinicians remain the constants in this evolving environment, sitting at the cutting edge of new evidence and innovation and at the coalface of clinical services which need to address the increasingly challenging health priorities we face as a society. Patients and clinicians, positioned centre stage in this changing world, must adjust their relationships and partnerships to reduce the burden of illness and ensure that multifaceted care needs are all properly addressed. In rare diseases, this relationship between patients and professionals demands a new model of care, in which patients are active, valued partners in their own care and function not as 'enlightened self-interested' individuals but as experts by experience. The unique characteristics of rare diseases demand that care evolves beyond multidisciplinary team care to 'Networked-care', in which care is prescribed based upon the body of experience and expertise of a community of experts and patients (who are experts by experience). Healthcare models are being redrawn around a new norm of clinical practice based on true patient-clinical partnerships in care. A partnership with patients, when supported by proper investment, is a collaborative relationship that aligns both the medical and clinical perspectives of professionals with a holistic perspective of patients' life experiences. Such partnerships can (i) ensure that decisions around care and design of services are needs-led, (ii) reduce the fog of uncertainty that surrounds rare diseases, (iii) amplify the success of new discoveries, and (iv) create breakthrough innovations: in these ways, patient-clinical partnerships increase the efficiency and effectiveness of our work and build a more sustainable future for our healthcare services.

Entities:  

Year:  2021        PMID: 33884523     DOI: 10.1007/s12687-021-00524-5

Source DB:  PubMed          Journal:  J Community Genet        ISSN: 1868-310X


  6 in total

1.  Building the business case for patient-centered care.

Authors:  Patrick A Charmel; Susan B Frampton
Journal:  Healthc Financ Manage       Date:  2008-03

Review 2.  How the EUCERD Joint Action supported initiatives on Rare Diseases.

Authors:  Stephen Lynn; Victoria Hedley; Antonio Atalaia; Teresinha Evangelista; Kate Bushby
Journal:  Eur J Med Genet       Date:  2017-01-10       Impact factor: 2.708

Review 3.  Mapping the impact of patient and public involvement on health and social care research: a systematic review.

Authors:  Jo Brett; Sophie Staniszewska; Carole Mockford; Sandra Herron-Marx; John Hughes; Colin Tysall; Rashida Suleman
Journal:  Health Expect       Date:  2012-07-19       Impact factor: 3.377

4.  Recommendations for patient engagement in guideline development panels: A qualitative focus group study of guideline-naïve patients.

Authors:  Melissa J Armstrong; C Daniel Mullins; Gary S Gronseth; Anna R Gagliardi
Journal:  PLoS One       Date:  2017-03-20       Impact factor: 3.240

Review 5.  Involving men to improve maternal and newborn health: A systematic review of the effectiveness of interventions.

Authors:  Mariam Tokhi; Liz Comrie-Thomson; Jessica Davis; Anayda Portela; Matthew Chersich; Stanley Luchters
Journal:  PLoS One       Date:  2018-01-25       Impact factor: 3.240

Review 6.  The impact of patient advisors on healthcare outcomes: a systematic review.

Authors:  Anjana E Sharma; Margae Knox; Victor L Mleczko; J Nwando Olayiwola
Journal:  BMC Health Serv Res       Date:  2017-10-23       Impact factor: 2.655

  6 in total
  2 in total

Review 1.  Multidisciplinary Care of Patients with Inherited Metabolic Diseases and Epilepsy: Current Perspectives.

Authors:  Birutė Tumienė; Mireia Del Toro Riera; Jurgita Grikiniene; Rūta Samaitiene-Aleknienė; Rūta Praninskienė; Ahmad Ardeshir Monavari; Jolanta Sykut-Cegielska
Journal:  J Multidiscip Healthc       Date:  2022-03-25

2.  Designing rare disease care pathways in the Republic of Ireland: a co-operative model.

Authors:  A J Ward; D Murphy; R Marron; V McGrath; M Bolz-Johnson; W Cullen; A Daly; O Hardiman; A Lawlor; S A Lynch; M MacLachlan; J McBrien; S Ni Bhriain; J J O'Byrne; S M O'Connell; J Turner; E P Treacy
Journal:  Orphanet J Rare Dis       Date:  2022-04-11       Impact factor: 4.123

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.